Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Sequential Therapy for Refractory H. Pylori
NCT03658733Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Dec 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole, rabeprazole in Helicobacter pylori infection, sponsored by Shandong University. Status: unknown.
02
Drugs
esomeprazolerabeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03658733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658733.